Revisiting: PCOS and metabolic overlap: what is and is not studied — setting out what I have, and where I think it stops being reliable.
Trying to establish the boundary conditions on PCOS and metabolic overlap. The general claim is fine; I want to know where it stops holding, because that is where I am operating.
Three edge cases below, in increasing order of how far outside the usual range they sit.
Noted, and thank you for writing it out rather than summarising it.
Confirming post #7 from a second method, which matters more than confirming it from a second person.
The most useful reply I ever got about PCOS and metabolic overlap was a request to state my units. It sounds like pedantry and it has saved me twice.
Distinguishing three things in the PCOS and metabolic overlap discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that gets attached to both.
Taking post #41 at face value and following it one step further.
My position on PCOS and metabolic overlap is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
Building on post #45 rather than restating it.
If you are new and reading this thread for the answer to PCOS and metabolic overlap: the answer is conditional, the conditions are in the third reply, and the rest of the thread is worth skipping.
What I want from this PCOS and metabolic overlap thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Read the full topic (60 posts)
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
[2026 update] Cardiovascular risk: reading the outcome trials as a set
Posting this under the heading it deserves: Cardiovascular risk: reading the outcome trials as a set Everything below is what sits behind that. I have spent a fortnight trying to pin Cardiovascular risk down…
|
+99 | 103 | 32k | 11mo |
|
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Hypertension improvement: setting out the arithmetic in full,…
|
+74 | 79 | 1.1k | 10mo |
|
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 16k | 12h | |
|
Hepatic steatosis: what the MASH trial evidence supports — one year on
On the subject in the title: Hepatic steatosis: what the MASH trial evidence supports — one year on Working notes rather than a conclusion. Reading back through what has been written here about Hepatic…
|
2 | 4.1k | 6mo | |
|
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about osteoarthritis and mechanical versus metabolic…
|
+2 | 6 | 30k | 12h |
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Preparing for an appointment: one page, three questions
Posting this under the heading it deserves: Preparing for an appointment: one page, three questions Everything below is what sits behind that. A question about how to describe something to a clinician rather…
|
+28 | 32 | 57k | 11mo |
|
Why semaglutide's albumin binding is the whole reason weekly dosing works
Asking directly, because I could not find a straight answer: Why semaglutide's albumin binding is the whole reason weekly dosing works Putting the numbers in the first post, because a question about a…
|
2 | 63k | 5mo | |
|
Second pass at: Sleep tracking data and its considerable limitations
Posting this under the heading it deserves: Second pass at: Sleep tracking data and its considerable limitations Everything below is what sits behind that. A measurement question rather than a physiology one.…
|
2 | 59 | 12mo | |
|
Second pass at: When your prescriber and the evidence disagree
Second pass at: When your prescriber and the evidence disagree — setting out what I have, and where I think it stops being reliable. What changes if the standard account of prescriber is wrong? I ask because…
|
+51 | 55 | 9.2k | 2d |
|
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class
Second pass at: Obstructive sleep apnoea and a hard endpoint in this class — setting out what I have, and where I think it stops being reliable. Something about Obstructive sleep apnoea does not reconcile and…
|
2 | 726 | 14mo |